Showing results (781-790 of 4,124) with videos related to
Sort By:
Pageof 413
Human Gene Therapy|February 23, 2013
Prolonged gene expression in muscle is achieved without active immune tolerance using microrRNA 142.3p-regulated rAAV gene transferFlorence Boisgerault, David-Alexandre Gross, Maxime Ferrand, et al.Human Gene Therapy|February 23, 2013
Myocardial gene transfer: routes and devices for regulation of transgene expression by modulation of cellular permeabilityMichael G Katz, Anthony S Fargnoli, Charles R BridgesHuman Gene Therapy|March 29, 2013
Kinetics of adeno-associated virus serotype 2 (AAV2) and AAV8 capsid antigen presentation in vivo are identicalYi He, Marc S Weinberg, Matt Hirsch, et al.Human Gene Therapy|November 8, 2013
Immunogenicity and therapeutic efficacy of a dual-component genetic cancer vaccine cotargeting carcinoembryonic antigen and HER2/neu in preclinical modelsLuigi Aurisicchio, Daniela Peruzzi, Gloria Koo, et al.Human Gene Therapy|October 30, 2013
An emerging adeno-associated viral vector pipeline for cardiac gene therapyAravind Asokan, R Jude SamulskiHuman Gene Therapy|October 30, 2013
Gene therapy to stimulate angiogenesis to treat diffuse coronary artery diseaseStephen M Kaminsky, Todd K Rosengart, Jonathan Rosenberg, et al.Human Gene Therapy|August 22, 2014
Changing faces in virology: the dutch shift from oncogenic to oncolytic virusesZineb Belcaid, Martine L M Lamfers, Victor W van Beusechem, et al.Human Gene Therapy|June 19, 2023
Genome Editing in Ferret Airway Epithelia Mediated by CRISPR/Nucleases Delivered with Amphiphilic Shuttle PeptidesMeihui Luo, Jia Ma, Xue Cheng, et al.Human Gene Therapy|May 20, 2026
Optimization of Alpha-1 Antitrypsin Expression from Adeno-Associated Virus VectorsQiushi Tang, Debora Pires-Ferreira, Christian Mueller, et al.Human Gene Therapy|May 29, 2026
Capsid Engineering of Adeno-Associated Viruses for Targeted Gene Therapy in Kidney DiseasesMohammadreza Ghaffarzadeh-Esfahani, Yousof GheisariPageof 413